BIO-TECHNE CORP holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 258,674 | $15,166,057 | 0.26% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 8, 2025 |
| June 30, 2025 | 258,659 | $13,308,006 | 0.22% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 5, 2025 |
| Sept. 30, 2025 | 367,009 | $20,416,711 | 0.35% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 390,794 | $22,982,595 | 0.40% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 4, 2026 |
| March 31, 2026 | 182,869 | $9,556,734 | 0.19% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 4, 2026 |
| June 30, 2026 | 182,687 | $12,906,837 | 0.24% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 5, 2026 |
| Sept. 30, 2026 | 182,687 | $13,239,327 | 0.24% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 5, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.